Vycor Medical, Inc. (OTCMKTS:VYCO – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 19,092 shares, an increase of 186.2% from the August 15th total of 6,670 shares. Based on an average daily volume of 46,956 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.1% of the shares of the company are sold short.
Vycor Medical Stock Performance
Shares of VYCO stock opened at $0.07 on Friday. Vycor Medical has a 12 month low of $0.03 and a 12 month high of $0.20. The business’s 50 day moving average is $0.07 and its two-hundred day moving average is $0.07.
Vycor Medical Company Profile
Vycor Medical, Inc is a medical device company specializing in the design, development and manufacture of minimally invasive cranial access systems for use in neurosurgery. The company’s proprietary endoport platform is engineered to provide neurosurgeons with controlled, cannula-based access for intracranial procedures such as tumor biopsy, resection and hematoma drainage. By integrating visualization channels and atraumatic retraction technology, Vycor’s products are intended to reduce collateral damage to healthy brain tissue and streamline procedural workflows.
The company’s core portfolio includes its flagship endoport system along with complementary accessories such as obturators, sheaths and closure devices.
Further Reading
- Five stocks we like better than Vycor Medical
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Vycor Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vycor Medical and related companies with MarketBeat.com's FREE daily email newsletter.
